Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
CO2Lift is a professional-grade topical carboxytherapy treatment system that utilizes a patented gel-based delivery system to infuse the skin and underlying tissues with carbon dioxide. When applied, the gel generates CO2 on the skin's surface, which is absorbed into the tissues, triggering the physiological **Bohr effect**. This effect occurs when an increased concentration of carbon dioxide leads to a localized decrease in pH, reducing hemoglobin's affinity for oxygen and promoting the immediate release of oxygen into the surrounding tissues. This process enhances microcirculation, stimulates vasodilation, and promotes cellular repair. CO2Lift is primarily used in aesthetic medicine for skin rejuvenation and anti-aging, but it is also clinically evaluated for reducing postoperative bruising, pain, and inflammation following procedures such as liposuction.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on CO2Lift.